MRNA Coming back to solid LONG-Side tradable support JMHO
Moderna finalizes an agreement with Recipharm for aseptic drug manufacturing and fill-finish for COVID-19 vaccine supply outside the US
Moderna and Recipharm, a contract development and manufacturing organization, have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 Vaccine supply outside of the US. The activity will be performed in Recipharm's drug product manufacturing facility located in France.
Subject to regulatory approval of the vaccine in relevant countries outside of the US, it is anticipated that supply will commence in early 2021.
No comments:
Post a Comment